Literature DB >> 27198699

Arachnophobia alleviated by subthalamic nucleus stimulation for Parkinson's disease.

Niels Allert1, Sabrina M Gippert2, Bastian E A Sajonz3,4, Christoph Nelles5, Bettina Bewernick2, Thomas E Schlaepfer2, Volker A Coenen3,4.   

Abstract

We report on a Parkinson patient with motor fluctuations and dyskinesias in whom deep brain stimulation (DBS) of the subthalamic nucleus (STN) not only improved motor symptoms but also pre-existing arachnophobia. Arachnophobia had been unchanged by the course of Parkinson's disease but rapidly improved with STN-DBS. Both, motor effects and the improvement of arachnophobia were stable during 2 years follow-up. To our knowledge this is the first report on STN stimulation effects on a specific phobia.

Entities:  

Keywords:  Arachnophobia; Deep brain stimulation; Medial forebrain bundle; Parkinson; Specific phobia; Subthalamic nucleus

Mesh：

Year:  2016        PMID： 27198699     DOI： 10.1007/s00702-016-1546-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  23 in total

1.  Explaining clinical effects of deep brain stimulation through simplified target-specific modeling of the volume of activated tissue.

Authors:  B Mädler; V A Coenen
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

2.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.

Authors:  Karsten Witt; Christine Daniels; Julia Reiff; Paul Krack; Jens Volkmann; Markus O Pinsker; Martin Krause; Volker Tronnier; Manja Kloss; Alfons Schnitzler; Lars Wojtecki; Kai Bötzel; Adrian Danek; Rüdiger Hilker; Volker Sturm; Andreas Kupsch; Elfriede Karner; Günther Deuschl
Journal:  Lancet Neurol       Date:  2008-06-04       Impact factor: 44.182

Review 3.  Mood and behavioural effects of subthalamic stimulation in Parkinson's disease.

Authors:  Anna Castrioto; Eugénie Lhommée; Elena Moro; Paul Krack
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

4.  Sensation seeking in England and America: cross-cultural, age, and sex comparisons.

Authors:  M Zuckerman; S Eysenck; H J Eysenck
Journal:  J Consult Clin Psychol       Date:  1978-02

5.  Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Authors:  Meghan C Campbell; Kevin J Black; Patrick M Weaver; Heather M Lugar; Tom O Videen; Samer D Tabbal; Morvarid Karimi; Joel S Perlmutter; Tamara Hershey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

Review 6.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.

Authors:  Jeff M Bronstein; Michele Tagliati; Ron L Alterman; Andres M Lozano; Jens Volkmann; Alessandro Stefani; Fay B Horak; Michael S Okun; Kelly D Foote; Paul Krack; Rajesh Pahwa; Jaimie M Henderson; Marwan I Hariz; Roy A Bakay; Ali Rezai; William J Marks; Elena Moro; Jerrold L Vitek; Frances M Weaver; Robert E Gross; Mahlon R DeLong
Journal:  Arch Neurol       Date:  2010-10-11

7.  Fear of Spiders Questionnaire.

Authors:  J Szymanski; W O'Donohue
Journal:  J Behav Ther Exp Psychiatry       Date:  1995-03

Review 8.  Meta-analysis of functional brain imaging in specific phobia.

Authors:  Jonathan C Ipser; Leesha Singh; Dan J Stein
Journal:  Psychiatry Clin Neurosci       Date:  2013-05-28       Impact factor: 5.188

9.  Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson's disease.

Authors:  Sheng-Tzung Tsai; Sheng-Huang Lin; Shinn-Zong Lin; Jen-Yeu Chen; Chi-Wei Lee; Shin-Yuan Chen
Journal:  Neurosurgery       Date:  2007-11       Impact factor: 4.654

10.  Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

Authors:  Luc Mallet; Michael Schüpbach; Karim N'Diaye; Philippe Remy; Eric Bardinet; Virginie Czernecki; Marie-Laure Welter; Antoine Pelissolo; Merle Ruberg; Yves Agid; Jérôme Yelnik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-07       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.